Dr. ANATOLE CESSOT

Publications

Circulating Biomarkers in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus in the Pre-nephrectomy Setting. Mauge L, Phan L, Benhamouda N, Galy-Fauroux I, Badoual C, Topart D, Thiery-Vuillemin A, Le Moulec S, Guillot A, Cessot A, Mejean A, Albiges L, Tartour E, Fournier L, Helley D, Oudard S.Clin Oncol (R Coll Radiol). 2023 Mar;

How did we take care of our older cancer patients during the first COVID-19 wave? The French experience. Helissey C, Ghebriou D, Cessot A, Boudin L, Prieux C, Romeo E, Schernberg A, Grellier N, Joly C, Bauduceau O, Thibault C, Mamou E, Raynal G, Serey Eiffel S, Le Floch H, Ricard D, Brureau L.Bull Cancer. 2021 Jun;

Evaluation of medical practices in oncology in the context of the COVID-19 pandemic in France: Physicians’ point of view: the PRATICOVID study. Helissey C, Cessot A, Boudin L, Romeo E, Prieux C, Ghebriou D, Schernberg A, Grellier N, Joly C, Bauduceau O, Thibault C, Mamou E, Raynal G, Serey Eiffel S, Le Floch H, Ricard D, Brureau L.Cancer Med. 2020 Dec ;

Determinants of the interindividual variability in serum cytidine deaminase activity of patients with solid tumours. Cohen R, Preta LH, Joste V, Curis E, Huillard O, Jouinot A, Narjoz C, Thomas-Schoemann A, Bellesoeur A, Tiako Meyo M, Quilichini J, Desaulle D, Nicolis I, Cessot A, Vidal M, Goldwasser F, Alexandre J, Blanchet B.Br J Clin Pharmacol. 2019 Jun ;